Microfluidic homo- and hetero-geneous immunoassays: a tool to accelerate protein biomarker development.

摘要

Molecular biomarkers have the potential to change the face of medicine. The ability to identify patients who will respond to therapy, diagnose illness earlier and more accurately, and understand the underlying biochemical mechanisms of disease, would have tangible impacts on human health.